FDA Approves Two Generic Versions of Apixaban
These are the first approvals of a generic DOAC, despite apixaban being the third to market.
These are the first approvals of a generic DOAC, despite apixaban being the third to market.
Often we hear that for an athlete to succeed, to reach the highest level of a sport, he must have more than talent.He must have…
A Texas lawmaker has introduced a bill that would prohibit payers from using artificial intelligence to delay, deny or modify claims.
There is nothing more powerful than a focused life. It’s kind of like light. Light that is unfocused and diffused has no power. But if…
Systematic evaluation of the prognosis from sepsis-associated acute kidney disease (SA-AKD) using real-world data is limited. This study aimed to use data algorithms on the…
This multicenter secondary analysis of the FINEARTS-HF randomized clinical trial examines the treatment effect of finerenone, relative to placebo, on clinical outcomes based on postrandomization…
God is far more interested in changing your mind than changing your circumstances. We want God to take away all of our problems, pain, sorrow,…
The Heart of Medicine: Investing in Our Future As a cardiologist and medical educator, I am continually reminded of the profound honor it is to…
The current approach for diagnosing obesity – one defined solely by an individual’s body mass index – is inadequate.
BACKGROUND: Black patients, those with low socioeconomic status (SES), and those living in rural areas have elevated rates of major lower extremity amputation, which may…
This randomized clinical trial investigates whether a home-based mobile health cardiac rehabilitation intervention improves 6-minute walk distance in adults aged 65 years or older after…